{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:52:12Z","timestamp":1793339532618,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.diabres.2017.11.018","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T23:30:42Z","timestamp":1511911842000},"page":"52-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"special_numbering":"C","title":["Nanotechnology based approaches for anti-diabetic drugs delivery"],"prefix":"10.1016","volume":"136","author":[{"given":"Prashant","family":"Kesharwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bapi","family":"Gorain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Yeng","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Ann","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Chai Siaw","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Khai","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan Ming","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Yee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Mey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Haw","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2017.11.018_b0005","unstructured":"Kliegman R, Stanton BMD, Geme JS, Schor NF. Diabetes mellitus \u2013 ClinicalKey. Nelson textb pediatr; 2016. p. 2760\u201390.e4 [chapter 589]."},{"key":"10.1016\/j.diabres.2017.11.018_b0010","article-title":"Managing diabetes with nanomedicine: challenges and opportunities","volume":"14","author":"Veiseh","year":"2014","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.diabres.2017.11.018_b0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2017.11.018_b0020","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance","volume":"28","author":"NDD Group","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2017.11.018_b0025","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, A multicenter, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"Landon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2017.11.018_b0030","unstructured":"Nadkarni Prashant, Weinstock Ruth S. Carbohydrates \u2013 ClinicalKey. Henry\u2019s clin diagnosis manag by lab methods; 2017. p. 205\u2013220.e2 [chapter 16]."},{"key":"10.1016\/j.diabres.2017.11.018_b0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Collaboration","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2017.11.018_b0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-156-3-201202070-00011","article-title":"Clinical Guidelines Committee of the American College of Physicians, Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2017.11.018_b0045","first-page":"74","article-title":"Network pharmacology studies on the bioactive compounds and action mechanisms of natural products for the treatment of diabetes mellitus: a review","volume":"8","author":"Li","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabres.2017.11.018_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcme.2017.08.012","article-title":"An update on natural compounds in the remedy of diabetes mellitus: a systematic review","author":"Choudhury","year":"2017","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.diabres.2017.11.018_b0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projection for 2030","volume":"27","author":"Sarah","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.11.018_b0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13300-013-0034-y","article-title":"Adherence to therapies in patients with type 2 diabetes","volume":"4","author":"Garc\u00eda-P\u00e9rez","year":"2013","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2017.11.018_b0065","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.111.039453","article-title":"Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy","volume":"125","author":"Wadden","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2017.11.018_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/EJE-11-0022","article-title":"Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues","volume":"166","author":"Vaag","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2017.11.018_b0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2017.11.018_b0080","unstructured":"Wall Russell T. Endocrine disease \u2013 ClinicalKey. Stoelting\u2019s anesth co-existing dis; 2012. p. 376\u2013406 [chapter 19]."},{"key":"10.1016\/j.diabres.2017.11.018_b0085","doi-asserted-by":"crossref","unstructured":"Ornoy Asher, Weber-Sch\u00f6ndorfer Corinna. Hormones \u2013 ClinicalKey. Drugs dur pregnancy lact, 3rd ed., vol. 2.15; 2015. p. 413\u201350.","DOI":"10.1016\/B978-0-12-408078-2.00016-0"},{"key":"10.1016\/j.diabres.2017.11.018_b0090","series-title":"Insulin biosynthesis, secretion, structure, and structure-activity relationships","author":"Weiss","year":"2000"},{"key":"10.1016\/j.diabres.2017.11.018_b0095","unstructured":"Costanzo Linda S. Endocrine physiology \u2013 ClinicalKey. Physiol Ed.; n.d. p. 383\u2013446."},{"key":"10.1016\/j.diabres.2017.11.018_b0100","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Insulin Resistance and Prediabetes, (2014)."},{"key":"10.1016\/j.diabres.2017.11.018_b0105","first-page":"85","article-title":"Recent trends in diabetes treatment using nanotechnology","volume":"7","author":"Subramani","year":"2012","journal-title":"Dig J Nanomater Biostruct"},{"key":"10.1016\/j.diabres.2017.11.018_b0110","first-page":"689","article-title":"Novel applications of nanotechnology in medicine","volume":"130","author":"Surendiran","year":"2009","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.diabres.2017.11.018_b0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1096\/fj.04-2747rev","article-title":"Nanomedicine: current status and future prospects","volume":"19","author":"Moghimi","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.diabres.2017.11.018_b0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2013.10.055","article-title":"Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform","volume":"460","author":"Choudhury","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yrtph.2016.10.020","article-title":"Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion","volume":"82","author":"Gorain","year":"2016","journal-title":"Regul Toxicol Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0130","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1039\/C5TX00049A","article-title":"Toxicological assessment of PEG functionalized f-block rare earth phosphate nanorods","volume":"4","author":"Chall","year":"2015","journal-title":"Toxicol Res"},{"key":"10.1016\/j.diabres.2017.11.018_b0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.colsurfb.2013.12.016","article-title":"Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats","volume":"115","author":"Gorain","year":"2014","journal-title":"Colloids Surf B Biointerf"},{"key":"10.1016\/j.diabres.2017.11.018_b0140","first-page":"211","article-title":"Liposome-based drug delivery systems","volume":"51","author":"Langner","year":"1999","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.diabres.2017.11.018_b0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.diabres.2017.11.018_b0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720107782151269","article-title":"Liposomal drug delivery systems: an update review","volume":"4","author":"Samad","year":"2007","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.diabres.2017.11.018_b0155","first-page":"1","article-title":"Liposomal drug delivery systems\u2013clinical applications","volume":"55","author":"Goyal","year":"2005","journal-title":"Acta Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0160","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1517\/14712598.1.6.923","article-title":"Developments in liposomal drug delivery systems","volume":"1","author":"Maurer","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.diabres.2017.11.018_b0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.NAN.0000264712.26219.67","article-title":"Liposomal drug delivery","volume":"30","author":"Allison","year":"2007","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.diabres.2017.11.018_b0170","unstructured":"Wang J. Synthesis and evaluation of novel amphiphilic macromolecules as drug carriers and therapeutics. Rutgers The State University of New Jersey-New Brunswick; 2007. https:\/\/search.proquest.com\/openview\/baf3750d033e2c0106504d1836ba0aef\/1?pq-origsite=gscholar&cbl=18750&diss=y [accessed October 25, 2017]."},{"key":"10.1016\/j.diabres.2017.11.018_b0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1556-276X-9-185","article-title":"Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity","volume":"9","author":"Zhang","year":"2014","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.diabres.2017.11.018_b0180","first-page":"966","article-title":"Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice","volume":"25","author":"Wu","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.diabres.2017.11.018_b0185","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bm401580k","article-title":"Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration","volume":"15","author":"Agrawal","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.diabres.2017.11.018_b0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijpharm.2012.10.025","article-title":"Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media","volume":"441","author":"Hu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0200","first-page":"1155","article-title":"Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation","volume":"6","author":"Niu","year":"2011","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.diabres.2017.11.018_b0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/02652040903131293","article-title":"Entrapment enhancement of peptide drugs in niosomes","volume":"27","author":"Manosroi","year":"2010","journal-title":"J Microencapsul"},{"key":"10.1016\/j.diabres.2017.11.018_b0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/0110-5558.76435","article-title":"Niosome: a future of targeted drug delivery systems","volume":"1","author":"Kazi","year":"2010","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.diabres.2017.11.018_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7372306","article-title":"Niosomes as nanoparticular drug carriers: fundamentals and recent applications","volume":"2016","author":"Ag Seleci","year":"2016","journal-title":"J Nanomater"},{"key":"10.1016\/j.diabres.2017.11.018_b0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","article-title":"Niosomes: novel sustained release nonionic stable vesicular systems\u2014an overview","volume":"183\u2013184","author":"Mahale","year":"2012","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.diabres.2017.11.018_b0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40005-016-0249-9","article-title":"Niosomes: a potential tool for novel drug delivery","volume":"46","author":"Khan","year":"2016","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.diabres.2017.11.018_b0230","article-title":"Development and characterization of non-ionic surfactant vesicles(niosomes) for oral delivery of lornoxicam","volume":"4","author":"Bini","year":"2009","journal-title":"Int J Drug Dev Res"},{"key":"10.1016\/j.diabres.2017.11.018_b0235","first-page":"129","article-title":"A novel drug delivery system: niosomes review","volume":"2","author":"Lohumi Ashutosh","year":"2012","journal-title":"J Drug Deliv Ther"},{"key":"10.1016\/j.diabres.2017.11.018_b0240","first-page":"498","article-title":"Niosomes: a novel drug delivery system","volume":"1","author":"Madhav","year":"2011","journal-title":"Int J Res Pharm Chem"},{"key":"10.1016\/j.diabres.2017.11.018_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0001-8686(95)00242-I","article-title":"Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry","volume":"58","author":"Uchegbu","year":"1995","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.diabres.2017.11.018_b0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540590968891","article-title":"Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats","volume":"12","author":"Ning","year":"2005","journal-title":"Drug Deliv"},{"key":"10.1016\/j.diabres.2017.11.018_b0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2008-2231-21-7","article-title":"Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization","volume":"21","author":"Sankhyan","year":"2013","journal-title":"Daru J Fac Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0260","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/10717544.2013.779332","article-title":"Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system","volume":"20","author":"Hasan","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.diabres.2017.11.018_b0265","first-page":"2756","author":"Namdev","year":"2015","journal-title":"Preparation and in vivo characterization of niosomal carriers of the antidiabetic drug repaglinide"},{"key":"10.1016\/j.diabres.2017.11.018_b0270","first-page":"155","article-title":"Nanoparticle-mediated delivery of therapeutic drugs","volume":"29","author":"Ponnappan","year":"2015","journal-title":"Pharmaceut Med"},{"key":"10.1016\/j.diabres.2017.11.018_b0275","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.carbpol.2016.11.027","article-title":"Co-delivery of antineoplastic and protein drugs by chitosan nanocapsules for a collaborative tumor treatment","volume":"157","author":"Wu","year":"2017","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.diabres.2017.11.018_b0280","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.diabres.2017.11.018_b0285","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.addr.2008.09.001","article-title":"Polysaccharides-based nanoparticles as drug delivery systems","volume":"60","author":"Liu","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.diabres.2017.11.018_b0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles:applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.diabres.2017.11.018_b0295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.diabres.2017.11.018_b0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jddst.2017.03.003","article-title":"Nanoparticle drug delivery systems for inner ear therapy: an overview","volume":"39","author":"Valente","year":"2017","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.diabres.2017.11.018_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerf"},{"key":"10.1016\/j.diabres.2017.11.018_b0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","article-title":"Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates","volume":"233","author":"Sheng","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2017.11.018_b0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \u201cmucus-inert\u201d agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2017.11.018_b0320","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijpharm.2017.07.018","article-title":"Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy","volume":"529","author":"Choudhury","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0325","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.2174\/1381612822666161201143600","article-title":"Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route","volume":"23","author":"Choudhury","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.diabres.2017.11.018_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2017.03.042","article-title":"Recent update on nanoemulgel as topical drug delivery system","author":"Choudhury","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.diabres.2017.11.018_b0335","first-page":"2207","article-title":"Novel PLGA-based nanoparticles for the oral delivery of insulin","volume":"10","author":"Malathi","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.diabres.2017.11.018_b0340","doi-asserted-by":"crossref","first-page":"8410","DOI":"10.1039\/C5TB01554E","article-title":"Hemocompatible, antioxidative and antibacterial polypropylene prepared by attaching silver nanoparticles capped with TPGS","volume":"3","author":"Li","year":"2015","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.diabres.2017.11.018_b0345","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.diabres.2017.11.018_b0350","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/nn400630x","article-title":"Injectable nano-network for glucose-mediated insulin delivery","volume":"7","author":"Gu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.diabres.2017.11.018_b0355","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2007.09.008","article-title":"Tegafur loading and release properties of magnetite\/poly(alkylcyanoacrylate) (core\/shell) nanoparticles","volume":"125","author":"Arias","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2017.11.018_b0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.diabres.2017.11.018_b0365","first-page":"44","article-title":"A review about dendrimers: synthesis, types, characterization and applications","volume":"4","author":"Baig","year":"2015","journal-title":"Int J Adv Pharm Biol Chem"},{"key":"10.1016\/j.diabres.2017.11.018_b0370","first-page":"01","article-title":"Dendrimers: novel carriers for drug delivery","volume":"4","author":"Chaudhari","year":"2016","journal-title":"J Appl Pharm Res"},{"key":"10.1016\/j.diabres.2017.11.018_b0375","first-page":"142","article-title":"Dendrimers and their applications as novel drug delivery carriers","volume":"3","author":"Tripathy","year":"2013","journal-title":"J Appl Pharm Sci"},{"key":"10.1016\/j.diabres.2017.11.018_b0380","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejpb.2014.12.023","article-title":"Current nanotechnology approaches for the treatment and management of diabetic retinopathy","volume":"95","author":"Fangueiro","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0385","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/09205063.2015.1133155","article-title":"Dendrimer-mediated approaches for the treatment of brain tumor","volume":"27","author":"Dwivedi","year":"2016","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.diabres.2017.11.018_b0390","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.drudis.2014.09.019","article-title":"SiRNA nanotherapeutics: a Trojan horse approach against HIV","volume":"19","author":"Mishra","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.diabres.2017.11.018_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2016.12.007","article-title":"The use of nanoscaffolds and dendrimers in tissue engineering","author":"Gorain","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.diabres.2017.11.018_b0400","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2015.10.029","article-title":"Generation-dependent effect of PAMAM dendrimers on human insulin fibrillation and thermal stability","volume":"82","author":"Nowacka","year":"2016","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.diabres.2017.11.018_b0405","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1016\/j.biomaterials.2012.02.033","article-title":"A review of glycosylated carriers for drug delivery","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.diabres.2017.11.018_b0410","article-title":"Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery","author":"Kesharwani","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.diabres.2017.11.018_b0415","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.2174\/1381612820666150827094341","article-title":"Dendrimers as an effective nanocarrier in cardiovascular disease","volume":"21","author":"Gothwal","year":"2015","journal-title":"Curr Pharm Design"},{"key":"10.1016\/j.diabres.2017.11.018_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2016.06.029","article-title":"RNAi-combined nano-chemotherapeutics to tackle resistant tumors","author":"Tekade","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.diabres.2017.11.018_b0425","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1364\/BOE.2.001243","article-title":"Encapsulation of a Concanavalin A\/dendrimer glucose sensing assay within microporated poly (ethylene glycol) microspheres","volume":"2","author":"Cummins","year":"2011","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.diabres.2017.11.018_b0430","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijpharm.2014.01.011","article-title":"Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? \u2013 In the search for minimizing of the adverse effects of PAMAM administration","volume":"464","author":"Labieniec-Watala","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0435","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jps.22428","article-title":"Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats","volume":"100","author":"Dong","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.diabres.2017.11.018_b0440","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2008.08.001","article-title":"PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats","volume":"364","author":"Labieniec","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0445","first-page":"7","article-title":"Enhanced incretin effects of exendin-4 expressing chimeric plasmid based on two-step transcription amplification system with dendritic bioreducible polymer for the treatment of type 2 diabetes","volume":"1","author":"Kim","year":"2013","journal-title":"J Gene Ther"},{"key":"10.1016\/j.diabres.2017.11.018_b0450","doi-asserted-by":"crossref","unstructured":"Nowacka O, Mi\u0142owska K, Ionov M, Bryszewska M. Influence of PAMAM dendrimers on the human insulin; 2015: p. 20028. https:\/\/doi.org\/10.1063\/1.4937306.","DOI":"10.1063\/1.4937306"},{"key":"10.1016\/j.diabres.2017.11.018_b0455","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.colsurfb.2014.01.056","article-title":"Stabilizing effect of small concentrations of PAMAM dendrimers at the insulin aggregation","volume":"116","author":"Nowacka","year":"2014","journal-title":"Colloids Surf B Biointerf"},{"key":"10.1016\/j.diabres.2017.11.018_b0460","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.biochi.2010.06.002","article-title":"Use of poly(amido)amine dendrimers in prevention of early non-enzymatic modifications of biomacromolecules","volume":"92","author":"Labieniec","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.diabres.2017.11.018_b0465","unstructured":"Abumrad Nada A, Nassir Fatiha, Marcus Akiva. Digestion and absorption of dietary fat, carbohydrate, and protein \u2013 ClinicalKey. Sleisenger fordtran\u2019s gastrointest liver dis; 2016. p. 1736\u201364."},{"key":"10.1016\/j.diabres.2017.11.018_b0470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1142\/9781860949074_0005","article-title":"Polymer micelles as drug carriers","author":"Batrakova","year":"2006","journal-title":"Nanopart. Drug Carriers"},{"key":"10.1016\/j.diabres.2017.11.018_b0475","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1039\/C3RA47370H","article-title":"Polymeric micelles as drug delivery vehicles","volume":"4","author":"Ahmad","year":"2014","journal-title":"RSC Adv"},{"issue":"1","key":"10.1016\/j.diabres.2017.11.018_b0480","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/17425247.3.1.139","article-title":"Polymeric micelles for drug delivery","volume":"3","author":"Aliabadi","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.diabres.2017.11.018_b0485","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1021\/acs.chemmater.6b02965","article-title":"Cross-linked small-molecule micelle-based drug delivery system: concept, synthesis, and biological evaluation","volume":"28","author":"Liao","year":"2016","journal-title":"Chem Mater"},{"key":"10.1016\/j.diabres.2017.11.018_b0490","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/156720105774370221","article-title":"Lipid-core micelles for targeted drug delivery","volume":"2","author":"Torchilin","year":"2005","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.diabres.2017.11.018_b0495","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.diabres.2017.11.018_b0500","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.pnpbp.2008.05.005","article-title":"The total flavonoids extracted from Xiaobuxin-Tang up-regulate the decreased hippocampal neurogenesis and neurotrophic molecules expression in chronically stressed rats","volume":"32","author":"An","year":"2008","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiat"},{"key":"10.1016\/j.diabres.2017.11.018_b0505","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1039\/c3sm51538a","article-title":"Glucose-responsive complex micelles for self-regulated release of insulin under physiological conditions","volume":"9","author":"Yang","year":"2013","journal-title":"Soft Matter"},{"key":"10.1016\/j.diabres.2017.11.018_b0510","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/j.jconrel.2015.05.206","article-title":"Glucose-responsive micelles for insulin release","volume":"213","author":"Li","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.diabres.2017.11.018_b0515","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biomaterials.2015.11.007","article-title":"Nano-cage-mediated refolding of insulin by PEG-PE micelle","volume":"77","author":"Fang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.diabres.2017.11.018_b0520","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jfda.2015.01.007","article-title":"Application of polymeric nanoparticles and micelles in insulin oral delivery","volume":"23","author":"Alai","year":"2015","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.diabres.2017.11.018_b0525","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.nano.2015.05.006","article-title":"Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin","volume":"11","author":"Andrade","year":"2015","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.diabres.2017.11.018_b0530","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1208\/s12249-011-9647-5","article-title":"Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin","volume":"12","author":"Elsayed","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.diabres.2017.11.018_b0535","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1208\/s12249-013-9926-4","article-title":"Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation","volume":"14","author":"Manconi","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.diabres.2017.11.018_b0540","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2011.05.061","article-title":"Encapsulation enhancement and stabilization of insulin in cationic liposomes","volume":"415","author":"Park","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0545","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2006.03.014","article-title":"Pulmonary delivery of insulin by liposomal carriers","volume":"113","author":"Huang","year":"2006","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.diabres.2017.11.018_b0550","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2009.08.013","article-title":"Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect","volume":"382","author":"Hanato","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0555","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.msec.2014.10.070","article-title":"Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes","volume":"46","author":"Moghassemi","year":"2015","journal-title":"Mater Sci Eng, C"},{"key":"10.1016\/j.diabres.2017.11.018_b0560","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2006.08.002","article-title":"In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin","volume":"328","author":"Pardakhty","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0565","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1166\/jpsp.2015.1042","article-title":"Pioglitazone loaded vesicular carriers for anti-diabetic activity: development and optimization as per central composite design","volume":"2","author":"Haider","year":"2015","journal-title":"J Pharm Sci Pharmacol"},{"key":"10.1016\/j.diabres.2017.11.018_b0570","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0975-1483.57065","article-title":"Development and characterization of niosomal drug delivery of gliclazide","volume":"1","author":"Rathi","year":"2009","journal-title":"J Young Pharm"},{"key":"10.1016\/j.diabres.2017.11.018_b0575","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ijbiomac.2016.11.009","article-title":"Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats","volume":"95","author":"Saravanan","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.diabres.2017.11.018_b0580","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40199-015-0128-3","article-title":"Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles","volume":"23","author":"Ebrahimi","year":"2015","journal-title":"Daru"},{"key":"10.1016\/j.diabres.2017.11.018_b0585","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijpharm.2012.06.033","article-title":"Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood\u2013brain barrier permeability in streptozotocin diabetes in rats","volume":"436","author":"Karolczak","year":"2012","journal-title":"Int J Pharm"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717313037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717313037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T22:07:13Z","timestamp":1570399633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717313037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":117,"alternative-id":["S0168822717313037"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2017.11.018","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology based approaches for anti-diabetic drugs delivery","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2017.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}